GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Scaled Net Operating Assets

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Scaled Net Operating Assets : 0.45 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Jiangsu Hengrui Pharmaceuticals Co's operating assets for the quarter that ended in Sep. 2024 was ¥25,433 Mil. Jiangsu Hengrui Pharmaceuticals Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥3,919 Mil. Jiangsu Hengrui Pharmaceuticals Co's Total Assets for the quarter that ended in Jun. 2024 was ¥48,181 Mil. Therefore, Jiangsu Hengrui Pharmaceuticals Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.45.


Jiangsu Hengrui Pharmaceuticals Co Scaled Net Operating Assets Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Scaled Net Operating Assets Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.52 0.49 0.56 0.48

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.47 0.47 0.43 0.45

Competitive Comparison of Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets falls into.



Jiangsu Hengrui Pharmaceuticals Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(22939.352-2676.244)/42370.876
=0.48

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=43784.507 - 20845.155
=22939.352

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2751.42 - 75.176 - 0
=2676.244

Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(25432.631-3919.001)/48181.36
=0.45

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=48338.099 - 22905.468
=25432.631

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4006.581 - 51.305 - 36.275
=3919.001

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Hengrui Pharmaceuticals Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Hengrui Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
Executives
Zhang Lian Shan Directors, senior managers
Sun Xu Gen senior management
Yuan Kai Hong senior management
Zou Jian Jun senior management
senior management
Zhang Yue Hong senior management
Liu Xiao Han senior management
Zhou Yun Shu Directors, senior managers
Liao Cheng senior management
Wang Hong Sen senior management
Zhou Song senior management
Tao Wei Kang senior management
Jiang Su Mei senior management
Dai Hong Bin Directors, senior managers
Sun Jie Ping Directors, senior managers

Jiangsu Hengrui Pharmaceuticals Co Headlines

No Headlines